Patents by Inventor Anders Rudolf Hallberg

Anders Rudolf Hallberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tricyclic compounds useful as angiotensin II agonists
    Patent number: 8124638
    Abstract: There is provided compounds of formula (I), wherein X1, X2, X3, Y4, Y1, Y2, Y3, Y4, Z1, Z2, R4 and R5 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful as selective agonists of the AT2 receptor, and thus, in particular, in the treatment of inter alia gastrointestinal conditions, such as dyspepsia, IBS and MOF, and cardiovascular disorders.
    Type: Grant
    Filed: September 3, 2009
    Date of Patent: February 28, 2012
    Assignee: Vicore Pharma AB
    Inventors: Mathias Alterman, Anders Rudolf Hallberg
  • Tricyclic compounds useful as angiotensin II agonists
    Patent number: 7652054
    Abstract: There is provided compounds of formula (I), wherein X1, X2, X3, Y4, Y1, Y2, Y3, Y4, Z1, Z2, R4 and R5 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful as selective agonists of the AT2 receptor, and thus, in particular, in the treatment of inter alia gastrointestinal conditions, such as dyspepsia, IBS and MOF, and cardiovascular disorders.
    Type: Grant
    Filed: November 26, 2003
    Date of Patent: January 26, 2010
    Assignee: Vicore Pharma AB
    Inventors: Mathias Alterman, Anders Rudolf Hallberg
  • Tricyclic Compounds Useful as Angiotensin II Agonists
    Publication number: 20090326026
    Abstract: There is provided compounds of formula (I), wherein X1, X2, X3, Y4, Y1, Y2, Y3, Y4, Z1, Z2, R4 and R5 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful as selective agonists of the AT2 receptor, and thus, in particular, in the treatment of inter alia gastrointestinal conditions, such as dyspepsia, IBS and MOF, and cardiovascular disorders.
    Type: Application
    Filed: September 3, 2009
    Publication date: December 31, 2009
    Inventors: Mathias ALTERMAN, Anders Rudolf HALLBERG
  • Tricyclic compounds useful as angiotensin II agonists
    Publication number: 20040167176
    Abstract: There is provided compounds of formula (I), wherein X1, X2, X3, Y4, Y1, Y2, Y3, Y4, Z1, Z2, R4 and R5 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful as selective agonists of the AT2 receptor, and thus, in particular, in the treatment of inter alia gastrointestinal conditions, such as dyspepsia, IBS and MOF, and cardiovascular disorders.
    Type: Application
    Filed: November 26, 2003
    Publication date: August 26, 2004
    Inventors: Mathias Alterman, Anders Rudolf Hallberg
  • 3,3'-dithiobis (propionic acids) and esters thereof
    Patent number: 5889050
    Abstract: New 3,3'-dithiobis(propionic acids) and esters thereof with immunomodulating effect, processes for their preparation, pharmaceutical compositions containing them and methods of their pharmacological use.
    Type: Grant
    Filed: July 14, 1994
    Date of Patent: March 30, 1999
    Assignee: Astra Aktiebolag
    Inventors: Carl-Magnus Alexander Andersson, Sten H.ang.kan Axel Bergstrand, Anders Rudolf Hallberg, Bengt Olof Sarnstrand, Per Anders Sigvard Tunek
  • Pharmacological preparations comprising a cystine derivative
    Patent number: 5780508
    Abstract: The invention concerns pharmaceutical preparations for stimulation of the immune system which comprise a cystine derivative as active ingredient.
    Type: Grant
    Filed: June 1, 1995
    Date of Patent: July 14, 1998
    Assignee: Astra Aktiebolag
    Inventors: Carl-Magnus Alexander Andersson, H.ang.kan Sten Axel Bergstrand, Anders Rudolf Hallberg, Bengt Olof Sarnstrand, Anders Per Sigvard Tunek